series-b
Stage
2
Investors
About
Amal Therapeutics is a Swiss biotechnology company developing therapeutic cancer vaccines and immunotherapies using proprietary peptide-based platforms to elicit tumor-specific T cell responses for oncology indications.
Explore Amal Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.